SCHEMBL4948169

SCHEMBL4948169

Nc1cnccc1-c1ccc(Br)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.42
RPS6KA3 P51812 1/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC22A12 Q96S37 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
AXL P30530 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
AOC1 P19801 2/20 0.39
AOC3 Q16853 2/20 0.39
IMPDH2 P12268 1/20 0.39
CACNA1B Q00975 3/20 0.39
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
KDM6B O15054 1/20 0.37
KDM4A O75164 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29477093 0.83 CYP2D6 (0.46) RPS6KA3GAAKDM4ETDP1MEN1
SCHEMBL15770240 0.83 CYP2D6 (0.46) RPS6KA3GAAKDM4ETDP1MEN1
SCHEMBL20189888 0.80 RPS6KA3 (0.51) RPS6KA3GAAKDM4ESLC22A12ALDH1A1
SCHEMBL29939282 0.80 RPS6KA3 (0.51) RPS6KA3GAAKDM4ESLC22A12ALDH1A1
SCHEMBL21647182 0.80 RPS6KA3 (0.68) RPS6KA3KDM4ETDP1SLC22A12MEN1
SCHEMBL3164390 0.80 TDO2 (0.47) RPS6KA3GAAKDM4ESLC22A12MEN1
SCHEMBL3791281 0.79 ALDH1A1 (0.54) RPS6KA3KDM4ETDP1MEN1KMT2A
Ammonia Solution, Strong SCHEMBL16036667 0.78 RPS6KA3 (0.50) RPS6KA3GAAKDM4ESLC22A12ALDH1A1
SCHEMBL17506374 0.78 AOC1 (0.52) RPS6KA3GAAKDM4ETDP1MEN1
Hydrochloric Acid SCHEMBL16702548 0.78 ALDH1A1 (0.52) RPS6KA3KDM4ETDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893597-B1 AMPA RECEPTOR POTENTIATORS LILLY CO ELI (US) 2008-11-12 EP disclosed
US-7393868-B2 AMPA receptor potentiators ELI LILLY AND COMPANY (US) 2008-07-01 US disclosed
EP-1893597-A2 AMPA RECEPTOR POTENTIATORS ELI LILLY AND COMPANY (US) 2008-03-05 EP disclosed
US-20070142441-A1 AMPA receptor potentiators ELI LILLY AND COMPANY 2007-06-21 US disclosed
WO-2006132811-A2 AMPA RECEPTOR POTENTIATORS ELI LILLY AND COMPANY (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142441-A1 AMPA receptor potentiators GABRE, GRIN1, GRIK2 DGAT1 3137/4885RPS6KA3 2196/4885GAA 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.